Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Safety of L-Serine in Subjects With Amyotrophic Lateral Sclerois (ALS) at Varied Doses.

NCT01835782 is registered in ClinicalTrials.gov with Phoenix Neurological Associates, LTD as lead sponsor.

NCT NCT01835782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01835782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Safety of L-Serine in Subjects With Amyotrophic Lateral Sclerois (ALS) at Varied Doses.
Lead sponsor
Phoenix Neurological Associates, LTD
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
Not reported
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)